The University of Leeds has been awarded £3.87m by the Engineering and Physical Sciences Research Council to develop new testing methods for new knee therapies to treat osteoarthritis and other conditions.
The grant is part of the £17.7m funding that will develop new technologies to address the health issues of an ageing UK population, and has been announced by Universities and Science Minister Jo Johnson MP.
Professor Wilcox said: "Through this ambitious programme of research we will develop new testing methods that combine laboratory-based simulation and computer modelling to predict the performance of new therapies and implants for the knee and enable their design and usage to be optimised. Importantly, these tests will take into account the difference in patients' anatomy and knee function, as well as variations in device design and surgical technique.
"This will enable different therapies, or different variants of a device or implant, to be matched to different patient groups. We will also use the methods developed through this programme to demonstrate new emerging treatments for the knee including regenerative devices so they can be tested and optimised before costly clinical trials take place."
Discussing the £17.7 overall funding, Jo Johnson said: “The UK is a world leader in medical breakthroughs and home to innovative healthcare companies that know how to turn our expertise into good business.
"This investment will help diagnose cardiovascular diseases, treat debilitating illnesses, and ultimately improve the lives of millions of patients and their families.”
Professor Philip Nelson, Chief Executive of the Engineering and Physical Sciences Research Council (EPSRC), said: “More of us are living longer than before. It is vital for us to continue to invest in science and engineering research so we can ensure we have active, healthy and high quality later years. The EPSRC is striving to make the UK a healthy nation and one where research, discovery and innovation flourishes. These programmes will help deliver both of these objectives.”
Subscribe to our free fortnightly newsletter and stay ahead with the latest news in HE